It is often assumed that a decrease in memory and brain function are inevitable parts of aging, but a new study of centenarians suggests otherwise. The study focused on individuals over 100 years of age and their cognitive health.
Investigators found that despite the presence of neurological issues generally associated with Alzheimer’s disease (AD), many centenarians maintained high levels of cognitive performance.
Henne Holstege, Ph.D., assistant professor at Amsterdam University Medical Center said her interest in researching aging and cognitive health was inspired by the “fascinating” story of Hendrikje van Andel Schipper, who died at age 115 in 2005 “completely cognitively healthy.” Her mother, who died at age 100, was also cognitively intact at the end of her life.
Cognitive Decline and Aging
Despite findings of neuropathologic “hallmarks” of Alzheimer’s in the brains of the centenarians after their deaths, the markers were not associated with cognitive performance or rate of decline. These findings suggest that after reaching age 100 years, cognitive performance remains relatively stable during ensuing years. Therefore, these centenarians might be resilient or resistant to different risk factors of cognitive decline. It was also speculated that resilience may be attributable to greater cognitive reserve.
Are cognitively healthy centenarians resilient against further cognitive decline?
In this cohort study of 330 self-reported cognitively healthy centenarians, cognitive trajectories revealed only a slight decline in memory functioning, while other domains remained stable over time. Centenarians maintained high levels of cognitive performance despite being exposed to varying levels of risk factors of cognitive decline, including postmortem Alzheimer disease–associated neuropathologies.
These findings indicate that prolonged maintenance of cognitive functioning may be supported by mechanisms underlying resilience against risk factors of cognitive decline.
Notes on Cognitive Decline Testing with Centenarians
It is difficult enough to recruit and enroll 330 centenarians, but to then have neuropathological findings from 44 study participants who had timely neuropsychological assessments makes for a truly unique study. It is also notable that the neuropsychological assessments in the 100-plus Study were comprehensive, which is not the case for other studies of extremely old study participants that may rely only on a Mini-Mental Status Examination.
Cognitive and brain resilience are defined respectively by the level of cognitive function and brain tissue structural integrity in spite of a high degree of AD pathological burden. Rather than being resilient, individuals who live to age 100 years or more who do not have AD neuropathologic changes are considered resistant to AD.
By integrating neuropsychological assessments and neuropathological studies, subsets of centenarian cognitive super-agers and offspring who are either resistant or resilient to AD neuropathologic changes can be identified.
Neurofeedback Therapy
Here at Neurohealth Associates, we specialize in Neurofeedback treatments. Neurofeedback may be helpful if you are experiencing cognitive issues. The easy, noninvasive treatments can painlessly improve your mental health condition and outlook on life.
Schedule a consultation with NeuroHealth today and find out how we can help you.
Tags: brain health, brain mapping, clinical research, executive function, health, intelligence